Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying predictors for bacterial and fungal coinfection on chest computed tomography in patients with Pneumocystis pneumonia.
Wu HY, Wu KS, Huang YL, Dai SH, Chang DY, Kuo SH, Chen SY, Chou CC, Weng YW, Tseng YT, Chen JK, Sy CL, Tsai HC, Lee SS, Chen YS. Wu HY, et al. Among authors: chang dy. J Microbiol Immunol Infect. 2021 Aug;54(4):701-709. doi: 10.1016/j.jmii.2020.06.007. Epub 2020 Jun 26. J Microbiol Immunol Infect. 2021. PMID: 32660889 Free article.
An early precursor CD8 T cell that adapts to acute or chronic viral infection.
McManus DT, Valanparambil RM, Medina CB, Scharer CD, McGuire DJ, Sobierajska E, Hu Y, Chang DY, Wieland A, Lee J, Nasti TH, Hashimoto M, Ross JL, Prokhnevska N, Cardenas MA, Gill AL, Clark EC, Abadie K, Kumar A, Kaye J, Au-Yeung BB, Kueh HY, Kissick HT, Ahmed R. McManus DT, et al. Among authors: chang dy. Nature. 2025 Jan 8. doi: 10.1038/s41586-024-08562-y. Online ahead of print. Nature. 2025. PMID: 39778710
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer.
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY, Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K, Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K, Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y, Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara Y, Tamura K, Yonemori K. Noguchi E, et al. Among authors: chang dy. NPJ Breast Cancer. 2024 Aug 22;10(1):76. doi: 10.1038/s41523-024-00684-w. NPJ Breast Cancer. 2024. PMID: 39174547 Free PMC article.
Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2-positive early breast cancer: A meta-regression analysis.
Yang MH, Huang CS, Chang DY, Hu FC, Huang SM, Huang PH, Chen IC, Chen TW, Lin CH, Lu YS. Yang MH, et al. Among authors: chang dy. Cancer Med. 2024 Jul;13(14):e70005. doi: 10.1002/cam4.70005. Cancer Med. 2024. PMID: 39046067 Free PMC article.
245 results